Boudewijn Brans

Summary

Affiliation: Atrium Medical Centre
Country: The Netherlands

Publications

  1. ncbi request reprint Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative (131)I-lipiodol therapy
    B Brans
    Department of Nuclear Medicine, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium
    Eur J Nucl Med Mol Imaging 29:1374-9. 2002
  2. ncbi request reprint Clinical applications of newer radionuclide therapies
    Boudewijn Brans
    Department of Nuclear Medicine, Atrium Medical Centre, H Dunantstraat 5, Post Box 4446, 6401 CX Heerlen, The Netherlands
    Eur J Cancer 42:994-1003. 2006
  3. ncbi request reprint Depression and anxiety during isolation and radionuclide therapy
    B Brans
    Department of Nuclear Medicine, Ghent University Hospital, Ghent, Belgium
    Nucl Med Commun 24:881-6. 2003
  4. ncbi request reprint Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response
    B Brans
    Department of Nuclear Medicine, Ghent University Hospital, Belgium
    Nucl Med Commun 24:391-6. 2003
  5. ncbi request reprint Patient dosimetry for 131I-lipiodol therapy
    Myriam A Monsieurs
    Department of Anatomy, Embryology, Histology and Medical Physics, Faculty of Medicine, University of Ghent, Proeftuinstraat 86, 9000, Ghent, Belgium
    Eur J Nucl Med Mol Imaging 30:554-61. 2003
  6. doi request reprint Effect of the positron range of 18F, 68Ga and 124I on PET/CT in lung-equivalent materials
    Gerrit J Kemerink
    Department of Nuclear Medicine, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Eur J Nucl Med Mol Imaging 38:940-8. 2011
  7. doi request reprint Dosimetry in molecular nuclear therapy
    Roel Wierts
    Maastricht University Medical Center, Department of Nuclear Medicine, P Debyelaan 25, 6229HX Maastricht, The Netherlands
    Methods 55:196-202. 2011
  8. ncbi request reprint Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy
    Bart de Keizer
    Department of Nuclear Medicine, Room E02 222, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands
    Eur J Nucl Med Mol Imaging 30:367-73. 2003
  9. doi request reprint Molecular nuclear therapies for thyroid carcinoma
    Frederik A Verburg
    University of Aachen, Department of Nuclear Medicine, Germany
    Methods 55:230-7. 2011
  10. ncbi request reprint Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans
    Myriam Monsieurs
    Department of Medical Physics and Radiation Protection, Ghent University, Proeftuinstraat 86, 9000 Ghent, Belgium
    Eur J Nucl Med Mol Imaging 29:1581-7. 2002

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative (131)I-lipiodol therapy
    B Brans
    Department of Nuclear Medicine, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium
    Eur J Nucl Med Mol Imaging 29:1374-9. 2002
    ..These observations should be related to the impact of other treatment modalities on quality of life...
  2. ncbi request reprint Clinical applications of newer radionuclide therapies
    Boudewijn Brans
    Department of Nuclear Medicine, Atrium Medical Centre, H Dunantstraat 5, Post Box 4446, 6401 CX Heerlen, The Netherlands
    Eur J Cancer 42:994-1003. 2006
    ..The aim of a recently held workshop at the ECCO13 conference 2005 and this review is to inform the oncology community about these new developing therapies...
  3. ncbi request reprint Depression and anxiety during isolation and radionuclide therapy
    B Brans
    Department of Nuclear Medicine, Ghent University Hospital, Ghent, Belgium
    Nucl Med Commun 24:881-6. 2003
    ..Screening for trait anxiety before admission can be easily done and may guide interventions aimed at increasing patient comfort and acceptability...
  4. ncbi request reprint Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response
    B Brans
    Department of Nuclear Medicine, Ghent University Hospital, Belgium
    Nucl Med Commun 24:391-6. 2003
    ..This result may be extrapolated to similar types of intra-arterial, loco-regional hepatic radionuclide therapy...
  5. ncbi request reprint Patient dosimetry for 131I-lipiodol therapy
    Myriam A Monsieurs
    Department of Anatomy, Embryology, Histology and Medical Physics, Faculty of Medicine, University of Ghent, Proeftuinstraat 86, 9000, Ghent, Belgium
    Eur J Nucl Med Mol Imaging 30:554-61. 2003
    ..Except in the case of the smaller tumours, comparable results were obtained with MCNP and MIRDOSE. Due to hypersplenism, biological dosimetry results based on the MN assay are not reliable...
  6. doi request reprint Effect of the positron range of 18F, 68Ga and 124I on PET/CT in lung-equivalent materials
    Gerrit J Kemerink
    Department of Nuclear Medicine, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Eur J Nucl Med Mol Imaging 38:940-8. 2011
    ..The aim of this study was to investigate the effect of positron range on visualization and quantification in (18)F, (68)Ga and (124)I positron emission tomography (PET)/CT of lung-like tissue...
  7. doi request reprint Dosimetry in molecular nuclear therapy
    Roel Wierts
    Maastricht University Medical Center, Department of Nuclear Medicine, P Debyelaan 25, 6229HX Maastricht, The Netherlands
    Methods 55:196-202. 2011
    ..For this reason we restricted ourselves to reviewing the literature and highlighting relevant developments...
  8. ncbi request reprint Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy
    Bart de Keizer
    Department of Nuclear Medicine, Room E02 222, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands
    Eur J Nucl Med Mol Imaging 30:367-73. 2003
    ..RhTSH is therefore adequately satisfactory as an adjuvant tool in therapeutic settings and is especially suitable in advanced recurrent or metastatic DTC patients who may be intolerant to TSH stimulation by levothyroxine withdrawal...
  9. doi request reprint Molecular nuclear therapies for thyroid carcinoma
    Frederik A Verburg
    University of Aachen, Department of Nuclear Medicine, Germany
    Methods 55:230-7. 2011
    ..In this review, we will extensively discuss the aforementioned established therapeutic modalities and promising new concepts in molecular nuclear therapy of thyroid carcinoma...
  10. ncbi request reprint Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans
    Myriam Monsieurs
    Department of Medical Physics and Radiation Protection, Ghent University, Proeftuinstraat 86, 9000 Ghent, Belgium
    Eur J Nucl Med Mol Imaging 29:1581-7. 2002
    ..85 and the correction factor, 1.20. Our results show that it is feasible to use data from pre-therapy (123)I-MIBG scans to calculate the total body dose of the subsequent (131)I-MIBG therapy...
  11. doi request reprint Comparison of [18 F]FDG PET/CT and MRI in the diagnosis of active osteomyelitis
    Anastas Demirev
    Department of Nuclear Medicine, University Hospital of Maastricht, Maastricht, The Netherlands
    Skeletal Radiol 43:665-72. 2014
    ..In anticipation of the advent of hybrid PET/MRI scanners we analyzed our patient group to give direction to future imaging strategies in patients with suspected OM...
  12. doi request reprint ¹²⁴I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy ¹³¹I SPECT/CT
    Cecile de Pont
    Department of Nuclear Medicine, Maastricht University Medical Center, Postbox 5800, 6202 AZ Maastricht, The Netherlands
    Eur J Nucl Med Mol Imaging 40:693-700. 2013
    ..To compare pretherapy (124)I PET/CT and posttherapy (131)I SPECT/CT in the identification of pathological lesions and the staging of patients with differentiated thyroid carcinoma...
  13. doi request reprint Identification of a shine-through artifact in the trachea with (124)I PET/CT
    Sakar B Abdul-Fatah
    Department of Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
    J Nucl Med 50:909-11. 2009
    ..The effect is due to high-energy positrons that cross the air-filled trachea and annihilate at the opposite tracheal wall, incorrectly suggesting uptake at that location...
  14. doi request reprint Comparison of sentinel gamma probes for 99mTc breast cancer surgery based on NEMA NU3-2004 standard
    Mariangela Zamburlini
    Department of Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
    Nucl Med Commun 30:854-61. 2009
    ..Spatial resolution, sensitivity and angular resolution of the probes are believed to be determinant for the success of the identification of the sentinel node during radiosurgery...
  15. pmc Assessment of bone graft incorporation by 18 F-fluoride positron-emission tomography/computed tomography in patients with persisting symptoms after posterior lumbar interbody fusion
    Boudewijn Brans
    Department of Nuclear Medicine, University Medical Center Maastricht, Postbox 5800, Maastricht, 6202 AZ, The Netherlands
    EJNMMI Res 2:42. 2012
    ..abstract:..
  16. ncbi request reprint EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseases
    Jan Tennvall
    Department of Oncology, Lund University Hospital, 221 85 Lund, Sweden
    Eur J Nucl Med Mol Imaging 34:1324-7. 2007
    ..Today there remains a distinct subgroup of elderly patients with polycythaemia vera and essential thrombocythaemia for whom (32)P is the most optimal treatment option, an assertion supported by two large studies with long follow-up...
  17. ncbi request reprint EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)
    Jan Tennvall
    Department of Oncology, Lund University Hospital, 221 85, Lund, Sweden
    Eur J Nucl Med Mol Imaging 34:616-22. 2007
    ..The Therapy, Oncology and Dosimetry Committees have worked together in order to define some EANM guidelines on the use of Zevalin, paying particular attention to the problems related to nuclear medicine...
  18. doi request reprint EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy
    Francesco Giammarile
    CH Lyon Sud, EA 3738, HCL, UCBL, 165 Chemin du Grand Revoyet, 69495, Pierre Benite Cedex, France
    Eur J Nucl Med Mol Imaging 35:1039-47. 2008
    ....